This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

UCI-created stem cell treatment passes safety phase of clinical trial

June 4th, 2012

Doctors with the Balgrist University Hospital in Zurich have reported that a stem cell treatment developed in a collaboration among UCI's Aileen Anderson and Brian Cummings (pictured), the campus's Sue & Bill Gross Stem Cell Research Center and StemCells Inc. has passed the first planned interim safety review of the Phase I/II spinal cord injury clinical trial, which indicates that the surgery, immunosuppression and cell transplants have been well tolerated.

The StemCells Inc.-sponsored trial is the only ongoing clinical study of neural stem cell transplantation in spinal cord injury. Enrollment is now open to patients in Europe, the U.S. and Canada with "incomplete" spinal cord injury.

Provided by University of California, Irvine

Citation: UCI-created stem cell treatment passes safety phase of clinical trial (2012, June 4) retrieved 6 August 2026 from https://sciencex.com/wire-news/100249022/uci-created-stem-cell-treatment-passes-safety-phase-of-clinical.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.